Prolonged Survival and Preserved Renal Graft Function in a Kidney Transplant Patient With Advanced Urothelial Carcinoma Using an Immune Checkpoint Inhibitor: A Case Report-Reference-Cited by-同舟云学术

Prolonged Survival and Preserved Renal Graft Function in a Kidney Transplant Patient With Advanced Urothelial Carcinoma Using an Immune Checkpoint Inhibitor: A Case Report

Published:2023-06-28 Issue:7 Volume:9 Page:e1509
ISSN:2373-8731
Container-title:Transplantation Direct
language:en
Short-container-title:

Author:

Mavichak Weerawaroon¹,Laowalert Suthanit²,Ativitavas Touch³,Rungprai Daraporn⁴⁵

Affiliation:

1. Blackpool Victoria Hospital, Blackpool, United Kingdom.

2. Kidney Transplant Institute, Department of Medicine, Praram 9 Hospital, Bangkok, Thailand.

3. Division of Medical Oncology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

4. Department of Pharmaceutical Care, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand.

5. Silpakorn University Research and Development Group in Pharmaceutical Care (SURP), Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference17 articles.

1. Clinical benefit of pembrolizumab in advanced urothelial cancer patients in real-life setting: an efficacy and safety monocentric study.;Dang;Curr Oncol,2022

2. First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study.;Balar;Lancet Oncol,2017

3. Immune checkpoint inhibitors and kidney toxicity: advances in diagnosis and management.;Seethapathy;Kidney Med,2021

4. A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant.;Murakami;Kidney Int,2021

5. Urologic malignancies in kidney transplantation.;Hickman;Am J Transplant,2018